Anesthesia-related mortality in pediatric patients: a systematic review

Leopoldo Palheta Gonzalez1, Wangles Pignaton, Priscila Sayuri Kusano

  • 1Universidade do Estado do Amazonas (UEA), Manaus, AM, Brazil.

Insights

Pediatric anesthesia-related mortality is low and similar globally. However, perioperative mortality is higher in Brazil and developing nations, often due to airway and cardiocirculatory events.

Area of Science:

  • Anesthesiology
  • Pediatric critical care
  • Public health

Background:

  • Perioperative and anesthesia-related mortality in pediatric patients remains a significant concern globally.
  • Variations in mortality rates exist between developed and developing countries.
  • Understanding trends and causes is crucial for improving patient safety.

Purpose of the Study:

  • To systematically review and evaluate the incidence and causes of perioperative and anesthesia-related mortality in pediatric patients.
  • To compare mortality rates in Brazil with those in developed and developing countries worldwide.
  • To identify key risk factors and causes of mortality.

Main Methods:

  • Systematic literature review of EMBASE, PubMed, LILACS, and SciElo databases (up to 2011).
  • Analysis of 20 selected trials, extracting data on patient numbers, time of death, and mortality rates.
  • Comparison of anesthesia-related and perioperative mortality rates across different regions and time periods.

Main Results:

  • Anesthesia-related mortality rates are similar (<1 per 10,000) in Brazil and developed countries, showing a declining trend.
  • Developing countries exhibit higher anesthesia-related mortality rates (2.4-3.3 per 10,000).
  • Pediatric perioperative mortality rates have increased, with higher rates in Brazil (9.8 per 10,000) and developing countries (10.7-15.9 per 10,000) compared to developed nations.

Conclusions:

  • Pediatric anesthesia-related mortality rates are comparable in Brazil and developed countries.
  • Pediatric perioperative mortality rates are notably higher in Brazil and developing countries.
  • Airway management issues and cardiocirculatory events are primary causes of mortality, highlighting areas for targeted prevention strategies.

Related Concept Videos

Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...